(Q41512850)

1 October 2017

title

The immunogenicity of antibody aggregates in a novel transgenic mouse model (English)

1 reference

1 October 2017

8

1 reference

1 October 2017

6

Martin Ebeling

1 reference

1 October 2017

Juliana Bessa

1

1 reference

1 October 2017

Sabine Boeckle

2

1 reference

1 October 2017

Hermann Beck

3

1 reference

1 October 2017

Thomas Buckel

4

1 reference

1 October 2017

Sonja Schlicht

5

1 reference

1 October 2017

Anna Kiialainen

7

1 reference

1 October 2017

Björn Boll

9

1 reference

1 October 2017

Thomas Weiser

10

1 reference

1 October 2017

Thomas Singer

11

1 reference

1 October 2017

Antonius G Rolink

12

1 reference

1 October 2017

Antonio Iglesias

13

1 reference

1 October 2017

publication date

29 January 2015

1 reference

1 October 2017

published in

Pharmaceutical Research

1 reference

1 October 2017

volume

32

1 reference

1 October 2017

issue

7

1 reference

1 October 2017

page(s)

2344-2359

1 reference

Antibodies to watch in 2010

1 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11095-015-1627-0

Immunogenicity of rDNA-derived pharmaceuticals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-015-1627-0

Immunogenicity of protein therapeutics: The key causes, consequences and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-015-1627-0

Bioequivalence and the immunogenicity of biopharmaceuticals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-015-1627-0

Effects of protein aggregates: an immunologic perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-015-1627-0

An industry perspective on the monitoring of subvisible particles as a quality attribute for protein therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-015-1627-0

Immunogenicity of therapeutic proteins: clinical implications and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-015-1627-0

How to systematically evaluate immunogenicity of therapeutic proteins - regulatory considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-015-1627-0

Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-015-1627-0

Prediction of immunogenicity: in silico paradigms, ex vivo and in vivo correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-015-1627-0

Immunogenicity of different stressed IgG monoclonal antibody formulations in immune tolerant transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-015-1627-0

Development of a human antibody tolerant mouse model to assess the immunogenicity risk due to aggregated biotherapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-015-1627-0

Feedback inhibition of immunoglobulin gene rearrangement by membrane mu, but not by secreted mu heavy chains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-015-1627-0

Allelic exclusion in transgenic mice carrying mutant human IgM genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-015-1627-0

Analysis of the human VH gene repertoire. Differential effects of selection and somatic hypermutation on human peripheral CD5(+)/IgM+ and CD5(-)/IgM+ B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-015-1627-0

Highly aggregated antibody therapeutics can enhance the in vitro innate and late-stage T-cell immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-015-1627-0

UV photodegradation of murine growth hormone: chemical analysis and immunogenicity consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-015-1627-0

T cell independent antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-015-1627-0

Neutralizing antiviral B cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-015-1627-0

Characterization of the Murine Antigenic Determinant, Designated L3T4a, Recognized by Monoclonal Antibody GK 1.5: Expression of L3T4a by Functional T Cell Clones Appears to Correlate Primarily with Class II MHC Antigen-Reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-015-1627-0

Aggregated recombinant human interferon Beta induces antibodies but no memory in immune-tolerant transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-015-1627-0

Reaction to the paper: interaction of polysorbate 80 with erythropoietin: a case study in protein-surfactant interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-015-1627-0

Antigen-specific human monoclonal antibodies from mice engineered with human Ig heavy and light chain YACs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-015-1627-0

High-avidity human IgG kappa monoclonal antibodies from a novel strain of minilocus transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-015-1627-0

Functional transplant of megabase human immunoglobulin loci recapitulates human antibody response in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-015-1627-0

From XenoMouse technology to panitumumab, the first fully human antibody product from transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-015-1627-0

Resolution of psoriasis upon blockade of IL-15 biological activity in a xenograft mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-015-1627-0

Human antibodies from transgenic animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-015-1627-0

Somatic generation of antibody diversity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-015-1627-0

A directory of human germ-line V kappa segments reveals a strong bias in their usage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-015-1627-0

Characterization of the human Ig heavy chain antigen binding complementarity determining region 3 using a newly developed software algorithm, JOINSOLVER.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-015-1627-0

Preferential utilization of specific immunoglobulin heavy chain diversity and joining segments in adult human peripheral blood B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-015-1627-0

Antibody responses in mice to particles formed from adsorption of a murine monoclonal antibody onto glass microparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-015-1627-0

Immune responses to oxidative neoepitopes on LDL and phospholipids modulate the development of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-015-1627-0

Oxidation of LDL and its clinical implication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-015-1627-0

T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-015-1627-0

Adaptive immunity and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-015-1627-0

Antibody response against Betaferon® in immune tolerant mice: involvement of marginal zone B-cells and CD4+ T-cells and apparent lack of immunological memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-015-1627-0

Clonal deletion of autoreactive B lymphocytes in bone marrow chimeras

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-015-1627-0

Peripheral deletion of self-reactive B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-015-1627-0

Transgenic mice and analysis of B-cell tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-015-1627-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-015-1627-0

Clonal deletion of autospecific B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-015-1627-0

Induction of self-tolerance in T cells but not B cells of transgenic mice expressing little self antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-015-1627-0

Structure and Function of Purified Monoclonal Antibody Dimers Induced by Different Stress Conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-015-1627-0

Antibody Response to Aggregated Human Interferon Alpha2b in Wild-type and Transgenic Immune Tolerant Mice Depends on Type and Level of Aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-015-1627-0

Antigen-specific human antibodies from mice comprising four distinct genetic modifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-015-1627-0

Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-015-1627-0

Induction of self-tolerance in mature peripheral B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-015-1627-0

Eradication of established tumors by a fully human monoclonal antibody to the epidermal growth factor receptor without concomitant chemotherapy

21 January 2018

1 reference

12 December 2020

The human immunoglobulin loci introduced into mice: V (D) and J gene segment usage similar to that of adult humans

1 reference

12 December 2020

The influence of antigen organization on B cell responsiveness

1 reference

12 December 2020

Immunogenicity of recombinant human interferon beta interacting with particles of glass, metal, and polystyrene

1 reference

12 December 2020

Strategies and challenges for the next generation of therapeutic antibodies

1 reference

12 December 2020

T helper cell unresponsiveness: Rapid induction in antigen-transgenic and reversion in non-transgenic mice

1 reference

12 December 2020

The potential immunogenicity of human insulin and insulin analogues evaluated in a transgenic mouse model

1 reference

12 December 2020

Investigation of the immunogenicity of different types of aggregates of a murine monoclonal antibody in mice

1 reference

12 December 2020

Protein aggregates seem to play a key role among the parameters influencing the antigenicity of interferon alpha (IFN-alpha) in normal and transgenic mice

1 reference

12 December 2020

Human anti-animal antibody interferences in immunological assays

1 reference

12 December 2020

The human heavy chain Ig V region gene repertoire is biased at all stages of B cell ontogeny, including early pre-B cells.

1 reference

12 December 2020

Immunogenicity of therapeutic monoclonal antibodies

1 reference

12 December 2020

Receptor editing in lymphocyte development and central tolerance.

1 reference

12 December 2020

10.1007/S11095-015-1627-0

Identifiers

DOI

1 reference

1 October 2017

1 reference